Functional dyspepsia: How could a biliary dyspepsia sub-group be recognized? A methodological approach

Italian Journal of Gastroenterology

Volumn 28, Issue 5, 1996, Pages 261-268

  Koch, M ^a   Capurso, G ^a  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

Gastro oesophageal reflux; Irritable bowel syndrome; Self reported questionnaires; Tauroursodeoxycholic acid; Visual analogue scale

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; TAUROURSODEOXYCHOLIC ACID;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG EFFICACY; DYSPEPSIA; FEMALE; GASTROINTESTINAL MOTILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ODDI SPHINCTER; PAIN; POSTPRANDIAL STATE;

ADULT; BILIARY TRACT DISEASES; DYSPEPSIA; FEMALE; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; TAUROCHENODEOXYCHOLIC ACID;

EID: 0030036217     PISSN: 03920623     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Thompson WG, Dotevall G, Drossman DA, Heaton KW, Kruis W. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterol Int 1989; 2: 92-5.
2. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyren O, Stanghellini V. Working Team Report. Functional dyspepsia: A classification with guidelines for diagnosis and management. Gastroenterol Int 1991; 4: 145-60.
3. Steinberg WM. Sphincter of Oddi dysfunction: a clinical controversy. Gastroenterology 1988; 95: 1409-15.
4. Bar Meir S, Halpern Z, Bardan E, Gilan T. Frequency of papillary dysfunction among cholecystectomized patients. Hepatology 1984; 4: 328-30.
5. Bachrach WH, Hofmann AF. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Dig Dis Sci 1982; 27: 833-56.
6. Angelico M, De Santis A, Capocaccia L. Biliary sludge: a critical update. J Clin Gastroenterol 1990; 12: 656-62.
7. Lee SP, Maher K, Nicholls JF. Origin and fate of biliary sludge. Gastroenterology 1988; 94: 170-6.
8. Toouli J, Roberts-Thompson IC, Dent J, Lee J. Manometric disorders in patients with suspected sphincter of Oddi dysfunction. Gastroenterology 1985; 88: 1243-50.
9. Venu RP, Geenen JE. Diagnosis of and treatment of diseases of the papilla. Clin Gastroenterol 1986; 15: 439-55.
10. Talley NJ, Zinmeister AR, Schelck CD, Melton LJ III. Dyspepsia and dyspepsia subgroups: a population based study. Gastroenterology 1992; 102: 1259-62.
11. Capurso L, Koch MM, Dezi A, Koch G, Di Ciocco U. Towards a quantitative diagnosis of dyspepsia: the value of clinical symptoms. The Dyspepsia Project Report, part 1. Ital J Gastroenterol 1988; 20: 191-202.
12. Talley NJ. Drug treatment of functional dyspepsia. Scand J Gastroenterol 1991; 26(suppl 182): 47-60.
13. Dobrilla G, Comberlato, M, Steele A. Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials. J Clin Gastroenterol 1989; 11: 169-78.
14. Klein KB. Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology 1988; 95: 232-41.
15. Thompson WG, Creed F, Drossman DA, Heaton KW, Mazzacca G. Working Team Report. Functional bowel disease and functional abdominal pain. Gastroenterology Intl 1992; 5: 75-91.
16. Talley NJ, Nyren O, Drossman DA, Heaton KW, Veldhuyzen van Zanten SJO, Koch MM, et al. The irritable bowel syndrome: towards optima design of controlled treatment trials. Gastroenterology Intl 1993; 6: 189-211.
17. Larsen S, Farup P, Flaten O, Osnes M. The multi-crossover model for classifying patients as responders to a given treatment. Scand J Gastroenterol 1991; 26: 763-73.
18. Kleveland PM, Larsen S, Sandvik L, Kristensen P, Johannessen T, Halfstad PE, et al. The effect of cimetidine in non-ulcer dyspepsia. Experience with a multicross over model. Scand J Gastroenterol 1985; 20: 19-24.
19. Johannessen T, Petersen H, Kristensen P, Fosstveld D, Kelveland PM, Dybdahl J, et al. Cimetidine on-demand in dyspepsia. Experience with randomized controlled single-subject trials. Scand J Gastroenterol 1992; 27: 189-95.
20. Guyatt GH, Sackett D, Taylor DW. Determining optimal therapy randomized trials in individual patients. N Engl J Med 1986; 314: 889-92.
21. Johannessen T, Fosstveld D, Petersen H. Statistical aspects of controlled single subject trials. Fam Pract 1990; 7: 325-58.
22. Pocock SJ. Clinical Trials: a Practical Approach. Chichester: John Wiley & Sons, 1983, pp. 110-2.
23. Maxton DG, Morris J, Whorwell PJ. Improving clinical trials in irritable bowel syndrome: some practical aspects. Eur J Gastroenterol Hepatol 1992; 4: 337-41.
24. Spiegelhalter DJ, Crean GP, Holden R, Knill-Jones RP. Taking a calculated risk: predictive scoring systems in dyspepsia. Scand J Gastroenterol 1987; 128 (suppl): 152-60.
25. Crean GP, Card WI, Beattie AD, Holden RJ, James WB, Knill-Jones RP, et al. Ulcer-like dyspepsia. Scand J Gastroenterol 1982; 17(suppl. 79): 9-15.
26. Koch MM, Capurso LB. A patient with dyspepsia: a model for decision analysis. In: Data Analysis for Clinical Medicine: the Quantitative Approach to Patient Care in Gastroenterology. Chalmers TC, Blum A, Buyse M, Hewitt P, Koch M, eds. Rome; International University Press, 1988: 175-82.
27. Chisholm EM, DeDombal FT, Giles GR. Validation of a self administered questionnaire to elicit gastrointestinal symptoms. BMJ 1985; 290: 1795-6.
28. Jones R, Lydeard S. Prevalence of symptoms of dyspepsia in the community. BMJ 1989; 290: 30-2.
29. Talley NJ, Phillips SF, Melton LJ III, Wiltgen C, Zinmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989; 111: 671-4.
30. Talley NJ, Phillips SF, Wiltgen CM, Zinmeeiter AR, Melton LJ III. Assessment of functional gastrointestinal disease: the Bowel Disease Questionnaire. Mayo Clin Proc 1990; 65: 1456-79.
31. Hausken T, Berstad A. Cisapride treatment of patients with non-ulcer dyspepsia and erosive prepyloric changes. A double-blind, placebo-controlled trial. Scand J Gastroenterol 1992; 27: 213-7.
32. Waldron B, Cullen PT, Kumar R, Smith D, Jankowski J, Hopwood D. Evidence for hypomotility in non ulcer dyspepsia: a prospective multifactorial study. Gut 1990; 32:246-51.
33. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1987; 67: 361-70.
34. Gracely RH, McGrath P, Dubner R. Validity and sensitivity of ratio scales of sensory and affective verbal pain description; manipulation of affect by diazepam. Pain 1978; 5: 19-29.
35. Johannessen T, Fjosne U, Kleveland PM. Cimetidine responders in non-ulcer dyspepsia. Scand J Gastroenterol 1988; 23: 327-36.
36. Spiegelhalter DJ, Knill-Jones RP. Statistical and knowledge-based approaches to clinical decision support systems, with an application in gastroenterology. J Royal Stat Proc series A 1984; 147: 35-77.
37. Spiegelhalter DJ, Crean GP, Holden R, Knill-Jones RP. Taking a calculated risk: predictive scoring systems in dyspepsia. Scand J Gastroenterol 1987; 128 (suppl): 152-60.
38. Seymour DG, Green M, Vaz FG. Making better decisions: construction of clinical scoring systems by the Spiegelhalter-Knill-Jones approach. BMJ 1990; 300: 223-6.